A recent Diaceutics study has shown that 64% of otherwise eligible cancer patients were not prescribed advanced precision medicine treatments. Instead, patients were given conventional treatments, and, in the worst of cases, had their lives cut short when they might have benefited from a targeted tr... Read more
This company has no teams yet
This company has no offices yet